Although study 542 showed no statistically significant differences between the two regimens in efficacy in a predominantly antiretroviral naïve patient population, the significance of these findings for antiretroviral experienced patients is unknown.
Selvom undersøgelse 542 ikke viste statistisk signifikante forskelle mellem de to regimer med hensyn til effekt i en overvejende antiretroviral naiv population, kendes signifikansen af disse fund for antiretrovirale behandlede patienter ikke.